PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D021D0005Drugs and biologicals — Genentech Usa, Inc

Genentech Usa, Inc holds $136.1M across 34 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 3 related awards in the incumbent pipeline. Set-aside status: Unrestricted.

Dla Troop Support
Awarding office
Genentech Usa, Inc
Recipient
—
Estimated value
6505
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberSPE2D021D0005
Also listed asSPE2D0-21-D-0005
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentGenentech Usa, Inc
UEISA85BMHCTXK5
PSC6505
Related solicitationSPE2D015R0002

Drugs and Biologicals is a federal Unrestricted award for Dla Troop Support held by Genentech Usa, Inc. Estimated value —. Related solicitation SPE2D015R0002.

Drugs and Biologicals. Latest action is a modification.

Want the durability read on SPE2D021D0005? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Genentech Usa, Inc — $136.1M obligated across 34 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($136.1M) · all agencies
Department of Health and Human Services (HHS)$134.6M · 99%Department of Defense (DOD)$1.6M · 1%
Open full company profile →

Related awards

Same incumbent
75A50325F80003
OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES
$45.1M
Jan 29, 2027
SPE2D026F0182
8512097379!OTHER MEDICAL
$912K
Jun 22, 2027
75A50325F80036
PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
$75.0M
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2D021D0005?

SPE2D021D0005 (Drugs and biologicals) is a Dla Troop Support award with an estimated value of —, currently held by Genentech Usa, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-21-D-0005?

SPE2D0-21-D-0005 is the dashed form of PIID SPE2D021D0005 (Drugs and biologicals), held by Genentech Usa, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D021D0005?

Dla Troop Support awarded SPE2D021D0005 to Genentech Usa, Inc.

Who is the incumbent on SPE2D021D0005?

Genentech Usa, Inc is the incumbent with $136.1M across 34 related awards in SCOUT’s public footprint.

When does Genentech Usa, Inc’s SPE2D021D0005 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on SPE2D021D0005? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2D021D0005